Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07DAP
|
|||
Former ID |
DNC013969
|
|||
Drug Name |
4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol
|
|||
Synonyms |
CHEMBL499124; SCHEMBL1397158; GTPL8785; Bibenzyl-2,2',4,4'-tetraol; BDBM50263336; compound 7 [PMID: 21334791]; 4,4''-(ethane-1,2-diyl)dibenzene-1,3-diol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H14O4
|
|||
Canonical SMILES |
C1=CC(=C(C=C1O)O)CCC2=C(C=C(C=C2)O)O
|
|||
InChI |
1S/C14H14O4/c15-11-5-3-9(13(17)7-11)1-2-10-4-6-12(16)8-14(10)18/h3-8,15-18H,1-2H2
|
|||
InChIKey |
WKIFTWPZTZUMRN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.